Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Nyxoah (NYXH)

Nyxoah SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:NYXH
DateTimeSourceHeadlineSymbolCompany
11/04/202421:30GlobeNewswire Inc.Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical OfficerEU:NYXHNyxoah SA
11/04/202421:30GlobeNewswire Inc.Nyxoah Nomme le Dr Maurits S. Boon, MD, au Poste de Chief Medical OfficerEU:NYXHNyxoah SA
11/04/202421:30GlobeNewswire Inc.Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical OfficerEU:NYXHNyxoah SA
29/03/202420:30GlobeNewswire Inc.Informations sur le nombre total de droits de vote et d'actionsEU:NYXHNyxoah SA
29/03/202420:30GlobeNewswire Inc.Information on the total number of voting rights and sharesEU:NYXHNyxoah SA
29/03/202420:30GlobeNewswire Inc.Information on the total number of voting rights and sharesEU:NYXHNyxoah SA
25/03/202406:05GlobeNewswire Inc.Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationEU:NYXHNyxoah SA
25/03/202406:05GlobeNewswire Inc.Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationEU:NYXHNyxoah SA
25/03/202406:05GlobeNewswire Inc.Nyxoah Fait Progresser sa Stratégie d'Accès aux Patients en Annonçant un Partenariat Stratégique avec l'American Association of Otolaryngology – Head & Neck Surgery FoundationEU:NYXHNyxoah SA
19/03/202420:05GlobeNewswire Inc.Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary EndpointsEU:NYXHNyxoah SA
19/03/202420:05GlobeNewswire Inc.Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary EndpointsEU:NYXHNyxoah SA
19/03/202420:05GlobeNewswire Inc.Nyxoah Annonce que l'Étude Pivot DREAM U.S. Atteint les Critères d'Évaluation PrimairesEU:NYXHNyxoah SA
05/03/202421:05GlobeNewswire Inc.Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsEU:NYXHNyxoah SA
05/03/202421:05GlobeNewswire Inc.Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2023EU:NYXHNyxoah SA
05/03/202421:05GlobeNewswire Inc.Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsEU:NYXHNyxoah SA
29/02/202421:30GlobeNewswire Inc.Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceEU:NYXHNyxoah SA
29/02/202421:30GlobeNewswire Inc.Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceEU:NYXHNyxoah SA
29/02/202421:30GlobeNewswire Inc.Nyxoah Participera à la 34ème Oppenheimer Annual Healthcare MedTech & Services ConferenceEU:NYXHNyxoah SA
15/02/202421:30GlobeNewswire Inc.Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024EU:NYXHNyxoah SA
15/02/202421:30GlobeNewswire Inc.Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024EU:NYXHNyxoah SA
15/02/202421:30GlobeNewswire Inc.Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l'Exercice 2023 le 5 Mars 2024EU:NYXHNyxoah SA
17/01/202421:05GlobeNewswire Inc.Nyxoah Announces 2024 Strategic PrioritiesEU:NYXHNyxoah SA
17/01/202421:05GlobeNewswire Inc.Nyxoah Announces 2024 Strategic PrioritiesEU:NYXHNyxoah SA
17/01/202421:05GlobeNewswire Inc.Nyxoah Annonce ses Priorités Stratégiques pour 2024EU:NYXHNyxoah SA
09/01/202421:05GlobeNewswire Inc.Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023EU:NYXHNyxoah SA
09/01/202421:05GlobeNewswire Inc.Nyxoah Annonce ses Résultats Préliminaires pour le Quatrième Trimestre et l'Année 2023EU:NYXHNyxoah SA
09/01/202421:05GlobeNewswire Inc.Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023EU:NYXHNyxoah SA
11/12/202306:30GlobeNewswire Inc.Nyxoah Annonce la Présentation d’une Série de Cas Démontrant des Résultats Positifs dans le Traitement des Patients atteints de CCC avec Genio®EU:NYXHNyxoah SA
11/12/202306:30GlobeNewswire Inc.Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®EU:NYXHNyxoah SA
11/12/202306:30GlobeNewswire Inc.Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®EU:NYXHNyxoah SA
 Showing the most relevant articles for your search:EU:NYXH